Management
DelvTech senior management and Board members have a proven track record in developing and commercialising a range of healthcare products globally. The mix of skills and experience includes alliances, equity transactions, licensing, public offerings, quality management, and regulatory and extensive international business experience.
Director
Mel Bridges has over 30 years of international business experience in the healthcare industry and holds a degree in Science. Mel’s experience includes CEO and co-founder of PANBIO (including Dr David Wyatt and Jim Kalokerinos) (publicly listed company on the ASX - PBO), and founder and Managing Director of Pacific Diagnostics (sold to US fortune 100 company Baxter Corp). He is the founder and major investor & shareholder in medical device manufacturer, Impedimed. Mel holds a number of board positions with publicly listed firms on the ASX. Mel is also Chairman of the Board of ASX 200 listed Peptech Limited and Alchemia Limited. He is a fellow of the Australian Institute of Company Directors.
Director
James Kalokerinos, BSc, BEcon, FAICD, has thirty years experience
in the biotech and healthcare industry both in Australia and
in overseas markets. He has worked extensively in the management
of sales, marketing, and distribution and in the commercialisation
of diagnostic devices. Mr Kalokerinos is a Fellow of the Australian
Institute of Company Directors, was a co-founder and Director
of Panbio Ltd (publicly listed company on the ASX - PBO),
and of Pacific Diagnostics (sold to U.S. fortune 100 company
Baxter Corporation). Mr Kalokerinos is a past Executive Chairman
of Panbio Ltd and is currently a non-executive Director of
DelvTech International. He has worked internationally for
more than twelve years and was the Market Director (Asia-Pacific)
for rapid test diagnostics company Quidel Corporation and
an International Director for Metra Biosystems.
Director
Dr Laurie Hammond is a founder and director of Timsco Pty
Ltd, an early-stage venture capital investor in new technology-based
enterprises. Timsco operates inQbator, an incubator of start-up
companies in information and communications technology and
bioinformatics, and manages a A$14 million fund. A new fund,
iQ Fund 2, is presently being raised for early-stage and expansion
investments in technology-based companies. Laurie has been
involved in national innovation support programs as a member
of the Commonwealth Government’s Industry Research &
Development Board, Chairman of the R&D Tax Concession
Committee, and a member of the Cooperative Research Centres
(CRC) Committee. He also is a member of Queensland’s
Food, Fibre and Agribusiness Council and the Gold Coast’s
Regional Economic Development Advisory Board.
Design and Engineering Manager
Ben Huber has worked in new product development for 7 years
since qualifying as an Industrial Designer (BBE-ID GDID).
Originally working for a leading design consultancy, as Product
Development Manager, Ben has been responsible for the product
design and development of a multitude of projects, from specialist
markets to large production consumables. Ben was subcontracted
by MediDive/DelvTech since late 2002 through his prior employer,
so has an intimate knowledge of DelvTech’s projects
and products.
Now solely employed by DelvTech, Ben is responsible for the design development and production management of DelvTech products. Utilising a broad knowledge of production and tooling processes combined with a passion for design, Ben has provided a vital link in the concept to reality phase.
|
